Injectable in situ gelling delivery system for the treatment of jawbone infections

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: A polymeric in situ gelling delivery system for localized and sustained delivery to jawbone infections was developed. Materials & methods: In situ gelling delivery systems were prepared using either Poly(dl-lactic acid) or chitosan and Pluronic F127/Pluronic F68. Metronidazole nanoparticles were prepared using poly(dl-lactide-co-glycolide) or chitosan. Poly(dl-lactide-co-glycolide) was used for microparticles. Particles were characterized for size, charge and morphology. Results: Viscosity and yield stress of the gels were 0.4 Pa.s and 2 Pa, respectively, with 70% cell viability over 72 h. Around 90% of loaded metronidazole was released at a sustained rate over 1 week. Conclusion: Use of appropriate amount of nano/microparticles in the gel resulted in a sustained release over a period of 1 week - needed for jawbone infection.

Cite

CITATION STYLE

APA

Dash, S., Singh, S., & Dash, A. K. (2021). Injectable in situ gelling delivery system for the treatment of jawbone infections. Therapeutic Delivery, 12(11), 775–788. https://doi.org/10.4155/tde-2021-0054

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free